A brand-name drug is a prescription medication sold under the name given to it by the pharmaceutical company that developed and holds the patent. Brand-name drugs are typically more expensive than their generic equivalents because the manufacturer can set prices without competition during the patent protection period, which usually lasts 20 years from the original filing date.
On most insurance formularies, brand-name drugs are placed on higher cost tiers than generics:
When a generic version of a brand-name drug becomes available (after patent expiration), it contains the same active ingredient, strength, and dosage form as the original and is FDA-approved as therapeutically equivalent. Switching to the generic typically results in significantly lower cost-sharing.
Your doctor can specify “dispense as written” (DAW) on a prescription if they believe the brand-name version is clinically necessary. In some cases, your insurer may require documentation to cover the brand-name drug when a generic is available.
Yes. Generic drugs contain the same active ingredient at the same strength and are approved by the FDA as therapeutically equivalent to the brand-name version. They must meet the same quality, safety, and efficacy standards. The main differences are in inactive ingredients (fillers, dyes), which rarely affect outcomes. For most people and most medications, the generic works the same as the brand.
Ask your insurer whether the brand-name drug requires prior authorization, and whether a formulary exception is available. Manufacturer patient assistance programs and coupons can reduce the cost of brand-name drugs for uninsured or high out-of-pocket patients — but check whether your plan’s accumulator rules count manufacturer coupon payments toward your deductible and out-of-pocket maximum (many don’t).
.svg)